Yang, Ming
Parikh, Neehar D.
Liu, Huixin
Wu, Elizabeth
Rao, Huiying
Feng, Bo
Lin, Andy
Wei, Lai
Lok, Anna S.
Funding for this research was provided by:
University of Michigan Health System and Peking University Health Sciences Center Joint Institute for Clinical and Translational Research
Bristol-Myers Squibb Foundation
Article History
Received: 8 August 2020
Accepted: 9 November 2020
First Online: 1 December 2020
Competing interests
: Anna S. Lok has received research grants from Bristol-Myers Squibb, TARGET PharmaSolutions, and Gilead, and has served as an advisor for Gilead and TARGET PharmaSolutions. Lai Wei has received research grants from Roche and Bristol-Myers Squibb, and has served as an advisor for Gilead and Abbott. Neehar D. Parikh has received research grants from Bayer, Exact Sciences, and Target PharmaSolutions, and he has served as a consultant for Bayer, Exelixis, Eli Lilly, Eisai, and Bristol Myers-Squibb. Other authors have no conflict of interests to disclose.